BlackBarn Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$24.1M |
| 2 |
VG
Venture Global Inc
VG
|
+$22.1M |
| 3 |
AZUL
Azul S.A.
AZUL
|
+$14.9M |
| 4 |
Occidental Petroleum
OXY
|
+$14.2M |
| 5 |
California Resources
CRC
|
+$10.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Veeco
VECO
|
+$33.9M |
| 2 |
American Express Global Business Travel
GBTG
|
+$11.2M |
| 3 |
Roivant Sciences
ROIV
|
+$8.43M |
| 4 |
DHC
Diversified Healthcare Trust
DHC
|
+$6.04M |
| 5 |
Amneal Pharmaceuticals
AMRX
|
+$4.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 69.27% |
| 2 | Healthcare | 16.58% |
| 3 | Technology | 4.42% |
| 4 | Energy | 3.45% |
| 5 | Utilities | 2.48% |
Similar funds
BlackBarn Capital Partners's Q2 2026 Portfolio in Review
As of Q2 2026, BlackBarn Capital Partners held 30 positions worth $1.19B, down 4.6% from $1.24B the previous quarter. Its ten largest holdings account for 82% of the portfolio.
BlackBarn Capital Partners deployed $37.1M of net new capital in Q2 2026, opening 9 new positions and adding to 3 existing holdings. Its largest new stake was UnitedHealth: 65,000 shares worth $27M.
By sector, the portfolio is most concentrated in Miscellaneous at 69% of assets, down from 76% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Roivant Sciences, an estimated $8.43M trimmed.
- BlackBarn Capital Partners's largest Q2 2026 buy was UnitedHealth: 65,000 shares worth $27M.
- BlackBarn Capital Partners added most to NXP Semiconductors in Q2 2026, an estimated $8.27M increase.
- BlackBarn Capital Partners's biggest Q2 2026 reduction was Roivant Sciences, cutting an estimated $8.43M.
- BlackBarn Capital Partners fully exited Veeco in Q2 2026, selling an estimated $33.9M.
- BlackBarn Capital Partners's ten largest holdings make up 82% of its $1.19B portfolio in Q2 2026.
- BlackBarn Capital Partners opened 9 new positions and closed 6 in Q2 2026.
- BlackBarn Capital Partners's portfolio value fell 4.6% quarter-over-quarter to $1.19B.
Based on BlackBarn Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.